Skip to content

    Asarfi Hospital

    543943
    Healthcare·12 May 2025
    Management Summary

    Asarfi Hospital reported strong financial performance for the second half of FY25, with revenue growing 43% to Rs. 120.6 crores and net profit surging 154% to Rs. 10.6 crores, driven by improved margins. The newly operational cancer hospital, now with 65 beds, and DNB course affiliation are key growth drivers. However, increased debtors and relatively low occupancy rates in the cancer hospital remain areas of focus for management. A significant discrepancy was noted in the reported Profit Before Tax figures and growth rate.

    Highlights

    5
    • Revenue from operations grew 43% on year-on-year basis to Rs.120.6 crores from Rs.84.4 crores in financial year 2024.

    • EBITDA grew by 47% on year-on-year to Rs.223.5 crores with EBITDA margin improving to 20% up from 19% last year.

    • Net profit surged to 154% to Rs.10.6 crores, last year it was Rs.4.2 crores with PAT margin expanding from 5% to 9%.

    • Our cancer hospital located in a 9.55 acres land parcel in Ranguni, Dhanbad, became operational in Quarter 1, 2025, currently operating with 65 beds, up from initial 50 beds.

    • We have been affiliated by National Board of Examination for running DNB Courses.

    Concerns

    3
    • Debtors increased by Rs. 15 crore this year, primarily from government schemes, impacting cash flow.

    • Gross debt is around Rs. 40 crore, requiring active management.

    • Cancer hospital occupancy is currently at 30%, necessitating efforts to increase utilization.

    What Changed1

    vs Q2 FY26

    Risks discussed4 → 3 (-1)

    Key financials

    Single quarter

    11 metrics
    1. 01Revenue from Operations₹120.6 Cr+42.9%YoY
    2. 02IPD Revenue₹99.1 Cr+10.1%YoY
    3. 03OPD Revenue₹19.7 Cr+42%YoY
    4. 04EBITDA₹223.5 Cr+47%YoY
    5. 05EBITDA Margin20%

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Debt

    Gross ₹40 crores

    M&A

    100-bed hospital

    acquisition · announced

    Liquidity

    Cash ₹1.3 crores

    20% of working capital limits are unused.

    Guidance & targets

    11
    CategoryTargetPriority
    Beds
    Total bed capacity
    500 beds
    High
    Revenue
    Total revenue
    Rs. 200 crores
    High
    Revenue
    Revenue capacity with current setup
    Rs. 300+ crores
    Medium
    Margin
    EBITDA margin
    23% to 25%
    High
    Occupancy
    Cancer hospital occupancy rate
    50%
    High
    Occupancy
    Multispeciality hospital occupancy rate
    70%
    High
    ARPOB
    Cancer hospital ARPOB
    45,000
    High
    ARPOB
    Multifacility segment ARPOB
    20,000
    Medium
    Radiation
    Radiations per day
    80
    High
    Employee Cost
    Employee cost growth
    not more than 20%
    Medium
    Market Position
    #1 hospital in Jharkhand
    #1
    High

    Debtors Reduction & Impact on Interest Cost/EBITDA

    Next quarter
    CurrentDebtors increased by Rs. 15 crore, total debt around Rs. 40 crore.
    TargetSignificant reduction in debtors, positive impact on interest cost and EBITDA.

    Why it matters

    Effective debtor management is crucial for improving cash flow and overall profitability, especially given the reliance on government schemes.

    Debtors position is already, we have internally red flagged it that anyhow we need to bring down the debtors. But because you are working with government organization a lot of things are not under our control. We have reduced the debtors of existing hospital this year. Further, we are having talks with our main debtors, and they have promised to make some payment in the first quarter. But, in coming days things will get better and debtors will be managed, we are working on that.

    How to verify

    capital_allocation.debt.gross_debt

    Risks & concerns

    3
    RiskSeverity

    Increased Debtors/Receivables

    Receivables increased by Rs. 15 crore, primarily from government schemes, leading to cash flow challenges and potential impact on interest costs. Management is actively working on debtor management and process improvements.Both acknowledged

    medium

    Low Capacity Utilization in Cancer Hospital

    The newly operational cancer hospital is currently at 30% occupancy, which is below the target of 50%. Management is implementing strategies like health talks and service expansion to improve utilization.Both acknowledged

    medium

    Land Dispute

    A historical land dispute is ongoing in the high court, but management states that Asarfi Hospital is no longer a party to the case and any judgment will not impact its operations.Both downplayed

    low

    Q&A highlights

    8

    “Mayank, because it requires a detailed... I will have to look at the numbers and then I will have to answer, kindly post this on our e-mail so that we can give you detailed reply of this.”

    Highlights potential accounting/reporting complexities or a lack of immediate clarity on financial statement reconciliation, requiring further follow-up.

    asked by Mayank Kapoor

    2 min read6 chapters

    Detailed Narrative

    01

    Strong Financial Performance in FY25

    Asarfi Hospital reported robust financial results for the second half of FY25, with revenue from operations growing 43% year-on-year to Rs. 120.6 crores from Rs. 84.4 crores in FY24. This growth was accompanied by a 47% increase in EBITDA to Rs. 223.5 crores, improving the EBITDA margin to 20% from 19% in the previous year. Net profit surged 154% to Rs. 10.6 crores from Rs. 4.2 crores, with the PAT margin expanding from 5% to 9%. A significant discrepancy was noted in the reported Profit Before Tax figures and growth rate, which management has been asked to clarify.

    02

    Cancer Hospital Operationalization and Growth Strategy

    The company's dedicated cancer hospital, located in Dhanbad, became operational in Q1 2025, currently operating with 65 beds, up from an initial 50. Management highlighted its deep commitment to providing specialized healthcare, including Jharkhand's first advanced linear accelerator. Despite a current occupancy rate of 30%, the hospital is actively engaging in health awareness programs and expanding services to build trust and increase utilization, targeting 50% occupancy and an ARPOB of 45,000, aligning with HCG's standards.

    03

    Operational Metrics and Capacity Utilization

    For FY25, the Super Speciality hospital achieved a bed occupancy rate of approximately 61%, serving over 10,576 inpatients and 1.05 lakh outpatients. The Average Revenue Per Occupied Bed (ARPOB) for the Super Speciality hospital increased to 17,505 from 17,177 last year, while the cancer hospital's ARPOB stood at approximately 30,500. The company aims for 70% occupancy in its multispeciality hospital and 50% in the cancer hospital, alongside increasing daily radiation treatments from 20 to 80.

    04

    Debtors Management and Working Capital Focus

    A key concern raised was the increase in debtors by Rs. 15 crore, primarily due to government-supported cashless schemes like Ayushman Bharat. Management acknowledged this challenge, stating that they are actively working on debtor management through internal red-flagging, weekly monitoring, and IT infrastructure improvements. They expressed confidence in balancing debtors and creditors to manage working capital without requiring additional external funding, as growth investments have already been made.

    05

    Future Expansion and Strategic Vision

    Asarfi Hospital has a strategic vision to reach 500 beds by FY27, which includes the acquisition of a 100-bed hospital in the current financial year and adding 50 beds to existing facilities. This expansion is expected to contribute Rs. 20 crores to the FY27 revenue target of Rs. 200 crores. The company also aims to become the #1 hospital in Jharkhand by January 1, 2027, by focusing on comprehensive services and attracting top clinicians.

    06

    Capital Allocation and Shareholder Returns

    The company stated that significant CAPEX investments for growth have already been made, and no further external funding is required for its expansion plans. Gross debt was noted to be around Rs. 40 crores. While no dividend was declared this quarter, management confirmed they are actively considering it and will proceed once the financial situation improves. The focus remains on utilizing existing infrastructure and managing costs aggressively to achieve targeted EBITDA margins of 23-25%.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.